Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Developmental vascular regression is regulated by a Wnt/β-catenin, MYC and CDKN1A pathway that controls cell proliferation and cell death.

Nayak G, Odaka Y, Prasad V, Solano AF, Yeo EJ, Vemaraju S, Molkentin JD, Trumpp A, Williams B, Rao S, Lang RA.

Development. 2018 Jun 14;145(12). pii: dev154898. doi: 10.1242/dev.154898.

PMID:
29777010
2.

Medical phycology 2017.

Todd JR, Matsumoto T, Ueno R, Murugaiyan J, Britten A, King JW, Odaka Y, Oberle A, Weise C, Roesler U, Pore RS.

Med Mycol. 2018 Apr 1;56(suppl_1):S188-S204. doi: 10.1093/mmy/myx162.

PMID:
29767780
3.

A novel technique of axillary vein puncture involving peripherally inserted central venous catheters for a small basilic vein.

Saijo F, Odaka Y, Mutoh M, Katayose Y, Tokumura H.

J Vasc Access. 2018 May;19(3):311-315. doi: 10.1177/1129729818757974. Epub 2018 Mar 29.

PMID:
29592529
4.

Prognostic impacts of Rho-kinase activity in circulating leucocytes in patients with vasospastic angina.

Nihei T, Takahashi J, Hao K, Kikuchi Y, Odaka Y, Tsuburaya R, Nishimiya K, Matsumoto Y, Ito K, Miyata S, Sakata Y, Shimokawa H.

Eur Heart J. 2018 Mar 14;39(11):952-959. doi: 10.1093/eurheartj/ehx657.

PMID:
29165549
5.

YAP/TAZ-CDC42 signaling regulates vascular tip cell migration.

Sakabe M, Fan J, Odaka Y, Liu N, Hassan A, Duan X, Stump P, Byerly L, Donaldson M, Hao J, Fruttiger M, Lu QR, Zheng Y, Lang RA, Xin M.

Proc Natl Acad Sci U S A. 2017 Oct 10;114(41):10918-10923. doi: 10.1073/pnas.1704030114. Epub 2017 Sep 25.

6.

Myeloid Wnt ligands are required for normal development of dermal lymphatic vasculature.

Muley A, Odaka Y, Lewkowich IP, Vemaraju S, Yamaguchi TP, Shawber C, Dickie BH, Lang RA.

PLoS One. 2017 Aug 28;12(8):e0181549. doi: 10.1371/journal.pone.0181549. eCollection 2017.

7.

Ciclopirox inhibits cancer cell proliferation by suppression of Cdc25A.

Shen T, Shang C, Zhou H, Luo Y, Barzegar M, Odaka Y, Wu Y, Huang S.

Genes Cancer. 2017 Mar;8(3-4):505-516. doi: 10.18632/genesandcancer.135.

8.

Plasma concentration of serotonin is a novel biomarker for coronary microvascular dysfunction in patients with suspected angina and unobstructive coronary arteries.

Odaka Y, Takahashi J, Tsuburaya R, Nishimiya K, Hao K, Matsumoto Y, Ito K, Sakata Y, Miyata S, Manita D, Hirowatari Y, Shimokawa H.

Eur Heart J. 2017 Feb 14;38(7):489-496. doi: 10.1093/eurheartj/ehw448.

PMID:
27694191
9.

Levels of formaldehyde vapor released from embalmed cadavers in each dissection stage.

Sugata Y, Miyaso H, Odaka Y, Komiyama M, Sakamoto N, Mori C, Matsuno Y.

Environ Sci Pollut Res Int. 2016 Aug;23(16):16176-82. doi: 10.1007/s11356-016-6744-8. Epub 2016 May 6.

10.

Enhanced Adventitial Vasa Vasorum Formation in Patients With Vasospastic Angina: Assessment With OFDI.

Nishimiya K, Matsumoto Y, Takahashi J, Uzuka H, Wang H, Tsuburaya R, Hao K, Ohyama K, Odaka Y, Miyata S, Ito K, Shimokawa H.

J Am Coll Cardiol. 2016 Feb 9;67(5):598-600. doi: 10.1016/j.jacc.2015.11.031. No abstract available.

11.

Construction of possible integrated predictive index based on EGFR and ANXA3 polymorphisms for chemotherapy response in fluoropyrimidine-treated Japanese gastric cancer patients using a bioinformatic method.

Takahashi H, Kaniwa N, Saito Y, Sai K, Hamaguchi T, Shirao K, Shimada Y, Matsumura Y, Ohtsu A, Yoshino T, Doi T, Takahashi A, Odaka Y, Okuyama M, Sawada J, Sakamoto H, Yoshida T.

BMC Cancer. 2015 Oct 16;15:718. doi: 10.1186/s12885-015-1721-z.

12.

Distinct preoptic-BST nuclei dissociate paternal and infanticidal behavior in mice.

Tsuneoka Y, Tokita K, Yoshihara C, Amano T, Esposito G, Huang AJ, Yu LM, Odaka Y, Shinozuka K, McHugh TJ, Kuroda KO.

EMBO J. 2015 Nov 3;34(21):2652-70. doi: 10.15252/embj.201591942. Epub 2015 Sep 30.

13.

Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: multicentre registry study of the Japanese coronary spasm association.

Takahashi J, Nihei T, Takagi Y, Miyata S, Odaka Y, Tsunoda R, Seki A, Sumiyoshi T, Matsui M, Goto T, Tanabe Y, Sueda S, Momomura S, Yasuda S, Ogawa H, Shimokawa H; Japanese Coronary Spasm Association.

Eur Heart J. 2015 Jan 21;36(4):228-37. doi: 10.1093/eurheartj/ehu313. Epub 2014 Sep 4.

PMID:
25189599
14.

Application of a combination of a knowledge-based algorithm and 2-stage screening to hypothesis-free genomic data on irinotecan-treated patients for identification of a candidate single nucleotide polymorphism related to an adverse effect.

Takahashi H, Sai K, Saito Y, Kaniwa N, Matsumura Y, Hamaguchi T, Shimada Y, Ohtsu A, Yoshino T, Doi T, Okuda H, Ichinohe R, Takahashi A, Doi A, Odaka Y, Okuyama M, Saijo N, Sawada J, Sakamoto H, Yoshida T.

PLoS One. 2014 Aug 15;9(8):e105160. doi: 10.1371/journal.pone.0105160. eCollection 2014.

15.

Elfn1 recruits presynaptic mGluR7 in trans and its loss results in seizures.

Tomioka NH, Yasuda H, Miyamoto H, Hatayama M, Morimura N, Matsumoto Y, Suzuki T, Odagawa M, Odaka YS, Iwayama Y, Won Um J, Ko J, Inoue Y, Kaneko S, Hirose S, Yamada K, Yoshikawa T, Yamakawa K, Aruga J.

Nat Commun. 2014 Jul 22;5:4501. doi: 10.1038/ncomms5501.

PMID:
25047565
16.

In vivo visualization of adventitial vasa vasorum of the human coronary artery on optical frequency domain imaging. Validation study.

Nishimiya K, Matsumoto Y, Takahashi J, Uzuka H, Odaka Y, Nihei T, Hao K, Tsuburaya R, Ito K, Shimokawa H.

Circ J. 2014;78(10):2516-8. Epub 2014 Jun 27. No abstract available.

17.

PI3K/Akt is involved in brown adipogenesis mediated by growth differentiation factor-5 in association with activation of the Smad pathway.

Hinoi E, Iezaki T, Fujita H, Watanabe T, Odaka Y, Ozaki K, Yoneda Y.

Biochem Biophys Res Commun. 2014 Jul 18;450(1):255-60. doi: 10.1016/j.bbrc.2014.05.108. Epub 2014 Jun 2.

PMID:
24944017
18.

Growth differentiation factor-5 promotes brown adipogenesis in systemic energy expenditure.

Hinoi E, Nakamura Y, Takada S, Fujita H, Iezaki T, Hashizume S, Takahashi S, Odaka Y, Watanabe T, Yoneda Y.

Diabetes. 2014 Jan;63(1):162-75. doi: 10.2337/db13-0808. Epub 2013 Sep 23.

19.

Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells.

Odaka Y, Xu B, Luo Y, Shen T, Shang C, Wu Y, Zhou H, Huang S.

Carcinogenesis. 2014 Jan;35(1):192-200. doi: 10.1093/carcin/bgt277. Epub 2013 Aug 8.

20.

Identification of a candidate single-nucleotide polymorphism related to chemotherapeutic response through a combination of knowledge-based algorithm and hypothesis-free genomic data.

Takahashi H, Kaniwa N, Saito Y, Sai K, Hamaguchi T, Shirao K, Shimada Y, Matsumura Y, Ohtsu A, Yoshino T, Takahashi A, Odaka Y, Okuyama M, Sawada J, Sakamoto H, Yoshida T.

J Biosci Bioeng. 2013 Dec;116(6):768-73. doi: 10.1016/j.jbiosc.2013.05.021. Epub 2013 Jun 29.

PMID:
23816762
21.

SLITRK6 mutations cause myopia and deafness in humans and mice.

Tekin M, Chioza BA, Matsumoto Y, Diaz-Horta O, Cross HE, Duman D, Kokotas H, Moore-Barton HL, Sakoori K, Ota M, Odaka YS, Foster J 2nd, Cengiz FB, Tokgoz-Yilmaz S, Tekeli O, Grigoriadou M, Petersen MB, Sreekantan-Nair A, Gurtz K, Xia XJ, Pandya A, Patton MA, Young JI, Aruga J, Crosby AH.

J Clin Invest. 2013 May;123(5):2094-102. doi: 10.1172/JCI65853. Epub 2013 Apr 1.

22.

Protothecosis: report of a case with 20-year follow-up, and review of previously published cases.

Todd JR, King JW, Oberle A, Matsumoto T, Odaka Y, Fowler M, Pore RS, Shahan TA, Yin L, Sanusi ID.

Med Mycol. 2012 Oct;50(7):673-89. doi: 10.3109/13693786.2012.677862. Epub 2012 May 9. Review.

PMID:
22571772
23.

Rapamycin inhibits lymphatic endothelial cell tube formation by downregulating vascular endothelial growth factor receptor 3 protein expression.

Luo Y, Liu L, Rogers D, Su W, Odaka Y, Zhou H, Chen W, Shen T, Alexander JS, Huang S.

Neoplasia. 2012 Mar;14(3):228-37.

24.

Cryptotanshinone activates p38/JNK and inhibits Erk1/2 leading to caspase-independent cell death in tumor cells.

Chen W, Liu L, Luo Y, Odaka Y, Awate S, Zhou H, Shen T, Zheng S, Lu Y, Huang S.

Cancer Prev Res (Phila). 2012 May;5(5):778-87. doi: 10.1158/1940-6207.CAPR-11-0551. Epub 2012 Apr 3.

25.

Zic2 hypomorphic mutant mice as a schizophrenia model and ZIC2 mutations identified in schizophrenia patients.

Hatayama M, Ishiguro A, Iwayama Y, Takashima N, Sakoori K, Toyota T, Nozaki Y, Odaka YS, Yamada K, Yoshikawa T, Aruga J.

Sci Rep. 2011;1:16. doi: 10.1038/srep00016. Epub 2011 Jun 17. Erratum in: Sci Rep.2011;1:49.

26.

Curcumin inhibits protein phosphatases 2A and 5, leading to activation of mitogen-activated protein kinases and death in tumor cells.

Han X, Xu B, Beevers CS, Odaka Y, Chen L, Liu L, Luo Y, Zhou H, Chen W, Shen T, Huang S.

Carcinogenesis. 2012 Apr;33(4):868-75. doi: 10.1093/carcin/bgs029. Epub 2012 Jan 31.

27.

Impaired cognitive function and altered hippocampal synapse morphology in mice lacking Lrrtm1, a gene associated with schizophrenia.

Takashima N, Odaka YS, Sakoori K, Akagi T, Hashikawa T, Morimura N, Yamada K, Aruga J.

PLoS One. 2011;6(7):e22716. doi: 10.1371/journal.pone.0022716. Epub 2011 Jul 27.

28.

Nutritional status is strongly correlated with grip strength and depression in community-living elderly Japanese.

Kaburagi T, Hirasawa R, Yoshino H, Odaka Y, Satomi M, Nakano M, Fujimoto E, Kabasawa K, Sato K.

Public Health Nutr. 2011 Nov;14(11):1893-9. doi: 10.1017/S1368980011000346. Epub 2011 Mar 23.

PMID:
21426623
29.

Genetic incorporation of human metallothionein into the adenovirus protein IX for non-invasive SPECT imaging.

Mathis JM, Bhatia S, Khandelwal A, Kovesdi I, Lokitz SJ, Odaka Y, Takalkar AM, Terry T, Curiel DT.

PLoS One. 2011 Feb 9;6(2):e16792. doi: 10.1371/journal.pone.0016792.

30.

Adenoviral delivery of Tousled kinase for the protection of salivary glands against ionizing radiation damage.

Palaniyandi S, Odaka Y, Green W, Abreo F, Caldito G, De Benedetti A, Sunavala-Dossabhoy G.

Gene Ther. 2011 Mar;18(3):275-82. doi: 10.1038/gt.2010.142. Epub 2010 Nov 4.

PMID:
21048794
31.

Murine rVEGF164b, an inhibitory VEGF reduces VEGF-A-dependent endothelial proliferation and barrier dysfunction.

Cromer W, Jennings MH, Odaka Y, Mathis JM, Alexander JS.

Microcirculation. 2010 Oct;17(7):536-47. doi: 10.1111/j.1549-8719.2010.00047.x. Erratum in: Microcirculation. 2010 Nov;17(8):669.

32.

Species-specific detection and quantification of common barnacle larvae from the Japanese coast using quantitative real-time PCR.

Endo N, Sato K, Matsumura K, Yoshimura E, Odaka Y, Nogata Y.

Biofouling. 2010 Nov;26(8):901-11. doi: 10.1080/08927014.2010.531389.

PMID:
21038150
33.

Expression of ZIC family genes in meningiomas and other brain tumors.

Aruga J, Nozaki Y, Hatayama M, Odaka YS, Yokota N.

BMC Cancer. 2010 Mar 3;10:79. doi: 10.1186/1471-2407-10-79.

34.

The influence of a high-fat dietary environment in the fetal period on postnatal metabolic and immune function.

Odaka Y, Nakano M, Tanaka T, Kaburagi T, Yoshino H, Sato-Mito N, Sato K.

Obesity (Silver Spring). 2010 Sep;18(9):1688-94. doi: 10.1038/oby.2009.513. Epub 2010 Jan 28.

35.

Priming of immune responses against transporter associated with antigen processing (TAP)-deficient tumours: tumour direct priming.

Li XL, Zhang D, Knight D, Odaka Y, Glass J, Mathis JM, Zhang QJ.

Immunology. 2009 Nov;128(3):420-8. doi: 10.1111/j.1365-2567.2009.03127.x.

36.

Effect of B7.1 costimulation on T-cell based immunity against TAP-negative cancer can be facilitated by TAP1 expression.

Li XL, Liu YY, Knight D, Odaka Y, Mathis JM, Shi R, Glass J, Zhang QJ.

PLoS One. 2009 Jul 24;4(7):e6385. doi: 10.1371/journal.pone.0006385.

37.

eIF4E-targeted suicide gene therapy in a minimal residual mouse model for metastatic soft-tissue head and neck squamous cell carcinoma improves disease-free survival.

Siegele B, Cefalu C, Holm N, Sun G, Tubbs J, Meschonat C, Odaka Y, DeBenedetti A, Ghali GE, Chu Q, Mathis JM, Li BD.

J Surg Res. 2008 Jul;148(1):83-9. doi: 10.1016/j.jss.2008.03.011. Epub 2008 Apr 9.

PMID:
18570935
38.

Antioxidation mechanism studies of caffeic acid: identification of antioxidation products of methyl caffeate from lipid oxidation.

Masuda T, Yamada K, Akiyama J, Someya T, Odaka Y, Takeda Y, Tori M, Nakashima K, Maekawa T, Sone Y.

J Agric Food Chem. 2008 Jul 23;56(14):5947-52. doi: 10.1021/jf800781b. Epub 2008 Jun 18.

PMID:
18558705
39.

Identification of geranic acid, a tyrosinase inhibitor in lemongrass (Cymbopogon citratus).

Masuda T, Odaka Y, Ogawa N, Nakamoto K, Kuninaga H.

J Agric Food Chem. 2008 Jan 23;56(2):597-601. Epub 2007 Dec 15.

PMID:
18081247
40.

Dicyema Pax6 and Zic: tool-kit genes in a highly simplified bilaterian.

Aruga J, Odaka YS, Kamiya A, Furuya H.

BMC Evol Biol. 2007 Oct 25;7:201.

41.

Tyrosinase inhibitory activity of ethanol extracts from medicinal and edible plants cultivated in okinawa and identification of a water-soluble inhibitor from the leaves of Nandina domestica.

Masuda T, Fujita N, Odaka Y, Takeda Y, Yonemori S, Nakamoto K, Kuninaga H.

Biosci Biotechnol Biochem. 2007 Sep;71(9):2316-20. Epub 2007 Sep 7.

42.

Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational control.

Stoff-Khalili MA, Rivera AA, Nedeljkovic-Kurepa A, DeBenedetti A, Li XL, Odaka Y, Podduturi J, Sibley DA, Siegal GP, Stoff A, Young S, Zhu ZB, Curiel DT, Mathis JM.

Breast Cancer Res Treat. 2008 Mar;108(1):43-55. Epub 2007 May 17.

43.

Effects of potassium alkalis and sodium alkalis on the dechlorination of o-chlorophenol in supercritical water.

Sun Z, Takahashi F, Odaka Y, Fukushi K, Oshima Y, Yamamoto K.

Chemosphere. 2007 Jan;66(1):151-7. Epub 2006 Sep 26.

PMID:
17005235
44.

Specific and nontoxic silencing in mammalian cells with expressed long dsRNAs.

Strat A, Gao L, Utsuki T, Cheng B, Nuthalapaty S, Mathis JM, Odaka Y, Giordano T.

Nucleic Acids Res. 2006 Aug 11;34(13):3803-10. Print 2006.

45.

Cancer-specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control.

Mathis JM, Williams BJ, Sibley DA, Carroll JL, Li J, Odaka Y, Barlow S, Nathan CO, Li BD, DeBenedetti A.

J Gene Med. 2006 Sep;8(9):1105-20.

PMID:
16802401
46.

Stone models without faces--part II: an international interview. Laboratory perspectives. Interview by Douglas A. Terry.

Magne M, Odaka Y, Hegenbarth E, Geller W, Adar P, Yarovesky U, Roberts M.

Pract Proced Aesthet Dent. 2001 May;13(4):311-3. No abstract available.

PMID:
11402772
47.

Protective effect of heme oxygenase induction in ischemic acute renal failure.

Shimizu H, Takahashi T, Suzuki T, Yamasaki A, Fujiwara T, Odaka Y, Hirakawa M, Fujita H, Akagi R.

Crit Care Med. 2000 Mar;28(3):809-17.

PMID:
10752834
48.

Nuclear import and subnuclear localization of the proto-oncoprotein ETO (MTG8).

Odaka Y, Mally A, Elliott LT, Meyers S.

Oncogene. 2000 Jul 27;19(32):3584-97.

49.

Prevention of halothane-induced hepatotoxicity by hemin pretreatment: protective role of heme oxygenase-1 induction.

Odaka Y, Takahashi T, Yamasaki A, Suzuki T, Fujiwara T, Yamada T, Hirakawa M, Fujita H, Ohmori E, Akagi R.

Biochem Pharmacol. 2000 Apr 1;59(7):871-80.

PMID:
10718346
50.

[Induction of anesthesia with midazolam and thiamylal].

Nishiyama T, Hirasaki A, Odaka Y, Ishii S, Ono T, Seto K.

Masui. 1994 Jun;43(6):818-22. Japanese.

PMID:
8072138

Supplemental Content

Support Center